Synchronous vs. Async AI Pipelines: Pick the Right One

For: A seed-to-Series-A digital health founder whose app has just added a second AI feature — one that triages patient intake forms, one that generates prescription summaries — and whose backend engineer is arguing that both should share the same request-response path because 'that's how we built the first one'

Your backend engineer is right that consistency is valuable. They are wrong that consistency means using the same request-response path for every AI feature. The patient triage form and the prescription summary look similar from an engineering org chart, but they have different user contracts — and in healthcare, the user contract is what determines whether you need a synchronous pipeline, an asynchronous one, or both.

This post gives you a decision rule you can apply to every AI feature you ship from here on out. It is opinionated, it acknowledges what each approach is bad at, and it ends with a clear "if A, do X" verdict.

The decision, stated crisply

For each AI feature, you are choosing between two pipeline shapes:

• Synchronous: The client sends a request, blocks on the inference, and the user's next action depends on the response arriving in that same HTTP cycle. Typical budget: under 2 seconds end-to-end before users start abandoning.
• Asynchronous: The client submits work, gets an acknowledgement immediately, and the result is delivered later via webhook, polling, push notification, or surfaced inside a different screen. The user's next action is not blocked.

The mistake most teams make is treating this as an infrastructure question ("can our servers handle it?"). It is actually a product contract question: is the user's next action blocked on the AI output, or not? Answer that honestly per feature, and the architecture follows.

Why your current setup is breaking

You shipped feature one — patient intake triage — synchronously because the clinician needed the triage score before they could route the patient. That was the correct call.

Then you bolted on prescription summarization the same way, because the code path was already there. Now every patient discharge holds an HTTP connection open for several seconds while an LLM generates a summary the patient will read on email or in the app twenty minutes later. The user's next action — closing the discharge screen — does not actually depend on the summary being ready. But your architecture says it does.

Three things start happening:

1. Tail latency creeps up. P99 inference latency spikes drag down every endpoint sharing the same worker pool.
2. Timeouts appear in unrelated flows. Load balancer and database connection limits start saturating because long-running synchronous LLM calls hold resources.
3. Cloud spend climbs nonlinearly. You provision peak capacity for features that didn't need peak capacity, because async could have smoothed the load.

The non-obvious part: this is a compliance decision too

Here is what your backend engineer probably hasn't thought about. In a synchronous pipeline, the audit trail is simple: one request, one response, one log line, one PHI access event. The error boundary is the HTTP call itself — if it fails, the user sees an error and you log it.

Asynchronous pipelines that touch PHI need a different audit trail. You now have:

• A submission event (PHI written to a queue)
• A processing event (PHI read from queue, sent to model)
• A result event (model output written somewhere)
• A delivery event (result surfaced to user or downstream system)

Each is a separate access of PHI, each needs HIPAA-grade logging, and each is a potential failure point that does not surface to the user immediately. If your message broker silently drops a job, the patient never gets their summary and no one knows for hours. Async pipelines need explicit dead-letter queues, retry policies with idempotency keys, and reconciliation jobs that catch the gaps. Synchronous pipelines don't — failure is visible immediately.

So async isn't "the same architecture, just with a queue." It's a different compliance posture. Build it like one.

The five axes that actually matter

Score every AI feature against these. Don't add weights, don't build a spreadsheet. Just answer them.

1. Is the user's next action blocked on the output?

If a clinician cannot route the patient without the triage score, the answer is yes. If the patient will read the prescription summary later, the answer is no. This is the single most important axis. If "no," you should default to async unless another axis forces you back.

2. What is the inference latency distribution?

Not the average — the P95 and P99. LLM inference has long tails. A summary that averages 3 seconds can take 15 on a bad sample. If your P99 exceeds your user-acceptable wait time, synchronous is fragile even when the product contract allows it.

3. What happens on failure?

In synchronous flows, failure is loud — the user retries or you show an error. In async, you need explicit failure handling: retry with backoff, dead-letter queues, alerts, and a manual reconciliation path. If your team isn't ready to operate that, async will hurt you more than it helps.

4. Does the output touch PHI or affect clinical decisions?

Clinical-decision-support outputs (triage scoring, drug interaction checks, dosage recommendations) have stricter audit and explainability requirements. Synchronous makes the audit trail simpler. Async is doable but requires more compliance engineering up front.

5. What's the throughput shape?

Bursty workloads (everyone uses the app between 8 and 10 AM) waste money on synchronous because you provision for peak. Async lets you smooth the load with a queue and run inference workers at higher utilization. If your traffic is bursty and the feature tolerates a few minutes of delay, async wins on cost alone.

Scoring the two options honestly

Synchronous AI inference

Good at:

• Simple mental model — request in, response out
• Audit trail is one event
• Failures are immediately visible to the user and to monitoring
• No queue infrastructure, no webhook infrastructure, no polling logic
• Fast to ship feature one

Bad at:

• Long-tail latency kills user experience for any inference over ~2 seconds
• Provisioning has to handle peak load, not average load
• One slow model can drag down unrelated endpoints sharing the worker pool
• Doesn't scale to LLMs with variable output length
• Forces the user to wait even when the product doesn't require it

Asynchronous AI inference

Good at:

• Decouples user-facing latency from model latency entirely
• Smooths bursty workloads, raises worker utilization, lowers infra spend
• Tolerates long-running or batched inference (multi-step agents, large context windows)
• Failures can be retried automatically without user-visible errors
• Lets you use cheaper or larger models when latency isn't the constraint

Bad at:

• Audit trail is multi-event — more compliance work for PHI
• Silent failures are possible if dead-letter queues and reconciliation aren't built
• Requires delivery mechanism (webhook, push, polling, in-app notification)
• Harder to debug — distributed tracing across queue boundaries
• UX has to accommodate "result not ready yet" states gracefully

The verdict: when to pick what

Apply this to each feature individually. Resist the urge to standardize on one path.

Go synchronous if:

• The user's next action is blocked on the output (triage routing, eligibility checks, real-time clinical decision support), and
• P99 inference latency is under your acceptable wait time (typically 2–3 seconds for clinician-facing, 5 seconds for back-office), and
• The output influences a clinical decision and you want the simplest possible audit trail

Examples that should stay synchronous: intake triage scoring, drug-interaction checks at the point of prescription, insurance eligibility verification, real-time symptom-checker responses.

Go async if:

• The user's next action does not depend on the output, or
• Inference is variable-length or routinely exceeds a few seconds (LLM summarization, report generation, multi-step agent workflows), or
• Traffic is bursty and you're overprovisioning to handle peaks, or
• You want to use a larger/cheaper model that doesn't meet real-time SLAs

Examples that should be async: prescription summaries, discharge note generation, claim coding suggestions, longitudinal patient pattern analysis, scheduled risk-stratification jobs, anything involving document OCR plus LLM extraction.

Hybrid (the case most teams miss):

Some features want a synchronous acknowledgement plus an async result. Example: a clinician submits a complex case for AI-assisted differential diagnosis. You return a synchronous "received, processing" with an estimated time, then push the result to their dashboard or via notification when ready. This pattern needs both pipelines wired together, but it's often the right answer for anything that takes more than 5 seconds but where the user is actively waiting.

Concrete architecture moves for your specific situation

Given your two features:

Patient intake triage: Keep synchronous. The clinician's routing decision depends on the score. Optimize the model for latency — smaller, distilled, possibly self-hosted. Isolate its worker pool from other features so it can't be starved.

Prescription summary: Move to async. The patient reads it later. Submit to a queue on discharge, generate with whatever model gives you the best quality (latency no longer matters), deliver via the existing notification path, and store the result against the encounter ID. Build the dead-letter queue and reconciliation job before you ship it — not after.

Both should write to the same PHI access audit log, but with different event schemas. Synchronous: one event per call. Async: events for submission, processing-start, processing-complete, delivery. This is non-negotiable for HIPAA.

For the queue itself, the boring choice is the right one — AWS SQS with a DLQ, or Redis Streams if you're already in that ecosystem. Don't over-engineer with Kafka for a couple of features per second.

What changes operationally

Going async means your on-call rotation needs new alerts: queue depth growing, DLQ non-empty, reconciliation job finding gaps, webhook delivery failures. Your support team needs a way to answer "where is my summary?" — which means a status endpoint per job. Your QA team needs to test the "result arrives 10 minutes later" path, not just the happy synchronous path.

None of this is hard. All of it gets forgotten when async is treated as "just add a queue."

How CodeNicely can help

We've built this exact split for healthcare products. On HealthPotli, the e-pharmacy platform, the AI drug-interaction checker had to be synchronous — pharmacists needed the answer before dispensing — while prescription OCR, insurance claim extraction, and longitudinal adherence analysis ran async on different queues with different retention and audit policies. Getting that separation right was the difference between a system that scaled and one that timed out under load.

If you're at the point where your second AI feature is straining the architecture you built for the first, that's the conversation worth having. Our AI Studio team works specifically with seed and Series-A founders on pipeline architecture decisions, HIPAA-compliant audit design, and migrating features between sync and async paths without breaking the user contract.

The takeaway

Don't standardize your AI pipeline shape across features. Standardize the decision rule. For each feature, ask: is the user blocked? If yes, synchronous. If no, async with proper failure handling and PHI audit design. The cost spike and timeout creep you're seeing now is the predictable result of skipping that question on feature two. It will keep getting worse with feature three, four, and five unless you fix the rule, not just the symptoms.

Frequently Asked Questions

Can a single AI feature use both synchronous and asynchronous paths?

Yes, and this is often the right answer for features that take 5–30 seconds. Return a synchronous acknowledgement with a job ID, then deliver the result via webhook, push notification, or polling. The clinician sees "processing" immediately and the actual output arrives without holding the HTTP connection open. Just make sure both halves write to the same audit log with linked event IDs.

How do I handle HIPAA audit logging in an async pipeline?

Every PHI access — queue write, queue read, model call, result write, result delivery — needs its own audit event with a shared correlation ID so you can reconstruct the full chain. Use immutable append-only logging (CloudWatch Logs with retention policies, or an equivalent), and build a reconciliation job that flags any submission without a matching delivery event within your SLA. Your BAA with the model provider has to cover the async storage path too, not just the inference call.

What message queue should I use for async AI inference in healthcare?

AWS SQS with a dead-letter queue is the boring, correct default if you're on AWS — it's HIPAA-eligible under a BAA, and the DLQ pattern is well-understood. Redis Streams works if you're already running Redis and don't need long retention. Avoid Kafka unless you have throughput that justifies it; the operational cost is real. Whatever you pick, encrypt at rest and in transit, and document the data flow for your compliance review.

How do I know if my current synchronous pipeline is actually causing the timeouts?

Look at P95 and P99 latency by endpoint, not averages. If your AI endpoints have long tails and your non-AI endpoints are also slowing down, you're likely seeing worker pool contention — synchronous LLM calls holding workers that other requests need. Isolate the AI workers into their own pool first; if the symptoms persist, the feature itself probably needs to move async.

How much will it cost and how long will it take to migrate a feature from sync to async?

It depends heavily on how your current code is structured, whether your audit logging already supports multi-event flows, and what delivery mechanism your app uses. Rather than guess from a blog post, contact CodeNicely for a personalized assessment — we can usually scope it after a short architecture review.